- 同
- Tilade
WordNet
- a silvery soft waxy metallic element of the alkali metal group; occurs abundantly in natural compounds (especially in salt water); burns with a yellow flame and reacts violently in water; occurs in sea water and in the mineral halite (rock salt) (同)Na, atomic number 11
PrepTutorEJDIC
- ソジウム,ナトリウム(金属元素;化学記号はNa)
Wikipedia preview
出典(authority):フリー百科事典『ウィキペディア(Wikipedia)』「2012/12/19 11:30:05」(JST)
[Wiki en表示]
Nedocromil
|
Systematic (IUPAC) name |
9-ethyl-4,6-dioxo-10-propyl-6,9-dihydro-4H-pyrano[3,2-g]quinoline-2,8-dicarboxylic acid |
Clinical data |
Trade names |
Alocril |
AHFS/Drugs.com |
monograph |
MedlinePlus |
a601243 |
Pregnancy cat. |
? |
Legal status |
POM (UK) ℞-only (US) |
Routes |
Inhalation and eye drops |
Pharmacokinetic data |
Protein binding |
89% |
Metabolism |
not metabolized |
Half-life |
~3.3 hours |
Excretion |
excreted unchanged |
Identifiers |
CAS number |
69049-73-6 Y |
ATC code |
R01AC07 R03BC03, S01GX04 |
PubChem |
CID 50294 |
DrugBank |
DB00716 |
ChemSpider |
45608 Y |
UNII |
0B535E0BN0 Y |
KEGG |
D05129 Y |
ChEBI |
CHEBI:7492 Y |
ChEMBL |
CHEMBL746 Y |
Chemical data |
Formula |
C19H17NO7 |
Mol. mass |
371.341 g/mol |
SMILES
- O=C\1c3c(N(/C(C(=O)O)=C/1)CC)c(c2O/C(=C\C(=O)c2c3)C(=O)O)CCC
|
InChI
-
InChI=1S/C19H17NO7/c1-3-5-9-16-10(13(21)7-12(18(23)24)20(16)4-2)6-11-14(22)8-15(19(25)26)27-17(9)11/h6-8H,3-5H2,1-2H3,(H,23,24)(H,25,26) Y
Key:RQTOOFIXOKYGAN-UHFFFAOYSA-N Y
|
Y (what is this?) (verify)
|
Nedocromil sodium is a medication used to prevent wheezing, shortness of breath, and other breathing problems caused by asthma. It is administered by an inhaler under the brand name Tilade (although its effects in this form are far less than those in albuterol or other well-known inhaler medications) and as an eye drop under the brand name Alocril. Liquid preparations are available in the UK under the name Rapitil for use for allergic eye reactions.[1]
Nedocromil is classified as a cromone. Nedocromil acts as a mast cell stabilizer, inhibits the degranulation of mast cells, prevents release of histamine and tryptase, so preventing the synthesis of prostaglandins and leukotrienes. US Production of inhaled nedocromil ceased in April 2008.[2]
References
- ^ "Nedocromil eye drops" (in English). 2007-02-02. http://www.patient.co.uk/showdoc/30003772. Retrieved 2009-08-04.
- ^ http://www.fda.gov/downloads/Drugs/DrugSafety/DrugShortages/ucm089433.pdf
Decongestants and other nasal preparations (R01)
|
|
Topical |
Sympathomimetics, plain
|
- Cyclopentamine
- Ephedrine
- Phenylephrine
- Oxymetazoline
- Tetryzoline
- Xylometazoline
- Naphazoline
- Tramazoline
- Metizoline
- Tuaminoheptane
- Fenoxazoline
- Tymazoline
- Epinephrine
|
|
Antiallergic agents,
excluding corticosteroids
|
- histamine antagonists (Levocabastine
- Antazoline
- Thonzylamine)
- mast cell stabilizer (some are also antihistamines) (Cromoglicic acid
- Nedocromil
- Azelastine
- Olopatadine
- Lodoxamide)
|
|
Corticosteroids
|
- Beclometasone
- Prednisolone
- Dexamethasone
- Flunisolide
- Budesonide
- Betamethasone
- Tixocortol
- Fluticasone
- Mometasone furoate
- Triamcinolone
- Ciclesonide
|
|
Other nasal preparations
|
- Cafaminol
- Calcium hexamine thiocyanate
- Retinol
- Ipratropium bromide
- Ritiometan
- Mupirocin
- Hexamidine
- Framycetin
- Hyaluronic acid
- Eucalyptus oil
|
|
|
Systemic use:
Sympathomimetics |
- Phenylpropanolamine
- Pseudoephedrine (+loratadine)
- Phenylephrine
- Phenylpropylamine
|
|
|
anat (n, x, l, c)/phys/devp
|
noco (c, p)/cong/tumr, sysi/epon, injr
|
proc, drug (R1/2/3/5/6/7)
|
|
|
|
Drugs for obstructive airway diseases: asthma/COPD (R03)
|
|
Adrenergics, inhalants |
Short acting β2-agonists |
- Salbutamol#/Levosalbutamol
- Fenoterol
- Terbutaline
- Pirbuterol
- Procaterol
- Bitolterol
- Rimiterol
- Carbuterol
- Tulobuterol
- Reproterol
|
|
Long acting β2-agonists (LABA) |
- Arformoterol
- Bambuterol
- Clenbuterol
- Formoterol
- Salmeterol
- Ultra LABA: Indacaterol
|
|
other |
- Epinephrine#
- Hexoprenaline
- Isoprenaline (Isoproterenol)
- Orciprenaline (Metaproterenol)
|
|
|
Glucocorticoids |
- Beclometasone#
- Budesonide
- Ciclesonide
- Fluticasone
- Mometasone
- Flunisolide
- Betamethasone
- Triamcinolone
|
|
Anticholinergics/
muscarinic antagonist |
- Aclidinium bromide
- Ipratropium bromide#
- Oxitropium bromide
- Tiotropium bromide
|
|
Mast cell stabilizers |
|
|
Xanthines |
- Doxofylline
- Enprofylline
- Theobromine
- Theophylline/Aminophylline/Choline theophyllinate
|
|
Eicosanoid inhibition |
Leukotriene antagonists |
- Montelukast
- Pranlukast
- Zafirlukast
|
|
Lipoxygenase inhibitor |
|
|
Thromboxane receptor antagonists |
|
|
|
Combination products |
- Budesonide/formoterol
- Fluticasone/salmeterol
- Ipratropium bromide/salbutamol
- Mometasone/formoterol
|
|
- #WHO-EM
- ‡Withdrawn from market
- Clinical trials:
- †Phase III
- §Never to phase III
|
anat (n, x, l, c)/phys/devp
|
noco (c, p)/cong/tumr, sysi/epon, injr
|
proc, drug (R1/2/3/5/6/7)
|
|
|
|
UpToDate Contents
全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.
English Journal
- Estrogen inhibits mast cell chymase release to prevent pressure overload-induced adverse cardiac remodeling.
- Li J1, Jubair S1, Janicki JS2.
- Hypertension.Hypertension.2015 Feb;65(2):328-34. doi: 10.1161/HYPERTENSIONAHA.114.04238. Epub 2014 Nov 17.
- Estrogen regulation of myocardial chymase and chymase effects on cardiac remodeling are unknown. To test the hypothesis that estrogen prevents pressure overload-induced adverse cardiac remodeling by inhibiting mast cell (MC) chymase release, transverse aortic constriction or sham surgery was perform
- PMID 25403608
- Genome-wide interrogation of longitudinal FEV1 in children with asthma.
- Wu K1, Gamazon ER, Im HK, Geeleher P, White SR, Solway J, Clemmer GL, Weiss ST, Tantisira KG, Cox NJ, Ratain MJ, Huang RS.
- American journal of respiratory and critical care medicine.Am J Respir Crit Care Med.2014 Sep 15;190(6):619-27. doi: 10.1164/rccm.201403-0460OC.
- RATIONALE: Most genomic studies of lung function have used phenotypic data derived from a single time-point (e.g., presence/absence of disease) without considering the dynamic progression of a chronic disease.OBJECTIVES: To characterize lung function change over time in subjects with asthma and iden
- PMID 25221879
- Classification of childhood asthma phenotypes and long-term clinical responses to inhaled anti-inflammatory medications.
- Howrylak JA, Fuhlbrigge AL, Strunk RC, Zeiger RS, Weiss ST, Raby BA; Childhood Asthma Management Program Research Group.
- The Journal of allergy and clinical immunology.J Allergy Clin Immunol.2014 May;133(5):1289-300, 1300.e1-12.
- BACKGROUND: Although recent studies have identified the presence of phenotypic clusters in asthmatic patients, the clinical significance and temporal stability of these clusters have not been explored.OBJECTIVE: Our aim was to examine the clinical relevance and temporal stability of phenotypic clust
- PMID 24892144
Japanese Journal
- Nedocromil sodium ophthalmic solution 2% twice daily in patients with allergic conjunctivitis
- Twice-daily and once-daily nedocromil sodium 2% ophthalmic solution for the treatment of seasonal allergic conjunctivitis
- Nedocromil sodium inhibits bradykinin- and antigen-induced plasma extravasation in guinea pig airways
Related Links
- ※この商品に関係するニュース記事へのリンクがページ最下部にあります。 「有効成分」 ネドクロミルナトリウム(Nedocromil Sodium) 「同一成分含有商品」 ティレード (ネドクロミルナトリム)インヘラー 2mg (112回分) (1個) 4220 円
- Nedocromil Sodium reference guide for safe and effective use from the American Society of Health-System Pharmacists (AHFS DI). ... References 1. Aventis. Tilade (nedocromil sodium) inhalation aerosol prescribing information.
Related Pictures